Sep 29, 2017 11:30 am UTC| Business
RUTHERFORD, N.J., Sept. 29, 2017 -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced it will be...
Sep 29, 2017 11:26 am UTC| Business
Press Release29 September 2017 - N° 26 SCOR is honored with two awards for itsNorth American Life and PC reinsurance businessby Reactions magazine SCOR was honored twice at Reactions magazine's North...
Immunovaccine to Present at Upcoming Investor Conferences
Sep 29, 2017 11:05 am UTC| Business
HALIFAX, Nova Scotia, Sept. 29, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced Chief Executive Officer Frederic Ors is scheduled to present an overview of...
Sep 29, 2017 11:00 am UTC| Business
Primary Endpoint Achieved - Statistically Significant Convulsive Seizure Reduction for ZX008 versus Placebo for Adjunctive Treatment of Seizures ZX008 Also Demonstrated Statistical Significance in All Key Secondary...
Sep 29, 2017 11:00 am UTC| Business
– FDA notified AveXis it may initiate pivotal trial based on a review of data provided by the company following CMC Type B meeting – – Product used in the pivotal trial will be from the...
Lalpina Hydrogen Founder Alfred Culbreth on Separating Noise from Naturalism
Sep 29, 2017 11:00 am UTC| Business
PLAYA VISTA, Calif., Sept. 29, 2017 -- In our daily life we’ve become accustomed to seeing words like ‘organic,’ ‘all-natural’ or similar catch phrases on an increasing number of food and beverage labels, even on those...
K2M Receives FDA Clearance for Next-Generation YUKON™ OCT Spinal System
Sep 29, 2017 11:00 am UTC| Business
LEESBURG, Va., Sept. 29, 2017 -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body...